• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. May 1979; 76(5): 2442–2446.
PMCID: PMC383618

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.

Abstract

Human B cell lymphoma and murine T cell leukemia can be initiated by several agents. The present paper formulates some thoughts on the role of cytogenetic changes in the subsequent neoplastic process. Initiation creates long-lived preneoplastic cells. In some respects, they are comparable to in vitro-transformed ("immortalized") cell lines that maintain a diploid karyotype and are not tumorigenic in vivo. The development of a tumorigenic ("autonomous") clone is dependent on additional changes at the genetic level. In human B and murine T cell lymphoma, there are characteristic nonrandom chromosomal changes. The 14q+ marker appears to play a key role in human B cell lymphomas. The reciprocal 8;14 translocation in Burkitt lymphoma is a specialized subclass within this category. In murine T cell leukemia, trisomy 15 is the predominant change. The clustering of these nonrandom changes to tumors derived from a certain cell type rather than to tumors induced by a given etiological agent has important implications for the understanding of the genetic control of cellular responsiveness to growth-regulating forces in vivo.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Klein G. Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease. Cold Spring Harb Symp Quant Biol. 1975;39(Pt 2):783–790. [PubMed]
  • Lindahl T, Klein G, Reedman BM, Johansson B, Singh S. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer. 1974 Jun 15;13(6):764–772. [PubMed]
  • zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970 Dec 12;228(5276):1056–1058. [PubMed]
  • Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. [PubMed]
  • Luka J, Lindahl T, Klein G. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines. J Virol. 1978 Sep;27(3):604–611. [PMC free article] [PubMed]
  • Fialkow PJ, Klein G, Giblett ER, Gothoskar B, Clifford P. Foreign-cell contamination in Burkitt tumours. Lancet. 1971 May 1;1(7705):883–886. [PubMed]
  • Fialkow PJ, Klein E, Klein G, Clifford P, Singh S. Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med. 1973 Jul 1;138(1):89–102. [PMC free article] [PubMed]
  • Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyö EM, Klein E. Characteristics of new cell lines derived from Burkitt lymphomas. Cancer. 1969 Jan;23(1):64–79. [PubMed]
  • Diehl V, Henle G, Henle W, Kohn G. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol. 1968 Jul;2(7):663–669. [PMC free article] [PubMed]
  • Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer. 1971 Nov 15;8(3):443–450. [PubMed]
  • Nilsson K, Pontén J. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer. 1975 Feb 15;15(2):321–341. [PubMed]
  • Miller G. Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale J Biol Med. 1971 Jun;43(6):358–384. [PMC free article] [PubMed]
  • Henle W, Diehl V, Kohn G, Zur Hausen H, Henle G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science. 1967 Sep 1;157(3792):1064–1065. [PubMed]
  • Gerper P, Whang-Peng J, Monroe JH. Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A. 1969 Jul;63(3):740–747. [PMC free article] [PubMed]
  • Moss DJ, Pope JH. Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J Gen Virol. 1972 Nov;17(2):233–236. [PubMed]
  • Frank A, Andiman WA, Miller G. Epstein-Barr virus and nonhuman primates: natural and experimental infection. Adv Cancer Res. 1976;23:171–201. [PubMed]
  • Klein G, Svedmyr E, Jondal M, Persson PO. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer. 1976 Jan 15;17(1):21–26. [PubMed]
  • Svedmyr E, Jondal M. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622–1626. [PMC free article] [PubMed]
  • Jondal M, Svedmyr E, Klein E, Singh S. Killer T cells in a Burkitt's lymphoma biopsy. Nature. 1975 May 29;255(5507):405–407. [PubMed]
  • Bakacs T, Svedmyr E, Klein E. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients. Cancer Lett. 1978 Apr;4(4):185–189. [PubMed]
  • Svedmyr E, Jondal M, Henle W, Weiland O, Rombo L, Klein G. EBV specific killer T cells and serologic responses after onset of infectious mononucleosis. J Clin Lab Immunol. 1978 Nov;1(3):225–232. [PubMed]
  • Britton S, Andersson-Anvret M, Gergely P, Henle W, Jondal M, Klein G, Sandstedt B, Svedmyr E. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. N Engl J Med. 1978 Jan 12;298(2):89–92. [PubMed]
  • zur Hausen H. Oncogenic Herpes viruses. Biochim Biophys Acta. 1975 Mar 20;417(1):25–53. [PubMed]
  • Gerber P, Pritchett RF, Kieff ED. Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J Virol. 1976 Sep;19(3):1090–1099. [PMC free article] [PubMed]
  • Rabin H, Neubauer RH, Hopkins RF, 3rd, Nonoyama M. Further characterization of a herpesvirus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate herpesviruses. Int J Cancer. 1978 Jun 15;21(6):762–767. [PubMed]
  • Falk LA, Henle G, Henle W, Deinhardt F, Schudel A. Transformation of lymphocytes by Herpesvirus papio. Int J Cancer. 1977 Aug 15;20(2):219–226. [PubMed]
  • Ohno S, Luka J, Falk L, Klein G. Detection of a nuclear, EBNA-type antigen in apparently EBNA-negative Herpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique. Int J Cancer. 1977 Dec 15;20(6):941–946. [PubMed]
  • Deinhardt FW, Falk LA, Wolfe LG. Simian herpesviruses and neoplasia. Adv Cancer Res. 1974;19(0):167–205. [PubMed]
  • Zech L, Haglund U, Nilsson K, Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer. 1976 Jan 15;17(1):47–56. [PubMed]
  • Nilsson K, Giovanella BC, Stehlin JS, Klein G. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer. 1977 Mar 15;19(3):337–344. [PubMed]
  • Manolov G, Manolova Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature. 1972 May 5;237(5349):33–34. [PubMed]
  • Fukuhara S, Rowley JD. Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer. 1978 Jul 15;22(1):14–21. [PubMed]
  • Fleischman EW, Prigogina EL. Karyotype peculiarities of malignant lymphomas. Hum Genet. 1977 Mar 14;35(3):269–279. [PubMed]
  • Mark J, Ekedahl C, Hagman A. Origin of the translocated segment of the 14q+ marker in non-Burkitt lymphomas. Hum Genet. 1977 May 10;36(3):277–282. [PubMed]
  • Yamada K, Yoshioka M, Oami H. A 14q+ marker and a late replicating chromosome No. 22 in a brain tumor: brief communication. J Natl Cancer Inst. 1977 Oct;59(4):1193–1195. [PubMed]
  • Kaiser-McCaw B, Epstein AL, Kaplan HS, Hecht F. Chromosome 14 translocation in African and North American Burkitt's lymphoma;. Int J Cancer. 1977 Apr 15;19(4):482–486. [PubMed]
  • Mitelman F, Levan G. Clustering of aberrations to specific chromosomes in human neoplasms. III. Incidence and geographic distribution of chromosome aberrations in 856 cases. Hereditas. 1978;89(2):207–232. [PubMed]
  • de-Thé G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978 Aug 24;274(5673):756–761. [PubMed]
  • O'CONOR GT. Malignant lymphoma in African children. II. A pathological entity. Cancer. 1961 Mar-Apr;14:270–283. [PubMed]
  • Burkitt DP. Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus. J Natl Cancer Inst. 1969 Jan;42(1):19–28. [PubMed]
  • Andersson M, Klein G, Zeigler JL, Henle W. Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature. 1976 Mar 25;260(5549):357–359. [PubMed]
  • McCaw BK, Hecht F, Harnden DG, Teplitz RL. Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2071–2075. [PMC free article] [PubMed]
  • Dofuku R, Biedler JL, Spengler BA, Old LJ. Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1515–1517. [PMC free article] [PubMed]
  • Wiener F, Ohno S, Spira J, Haran-Ghera N, Klein G. Chromosome changes (trisomies #15 and 17) associated with tumor progression in leukemias induced by radiation leukemia virus. J Natl Cancer Inst. 1978 Jul;61(1):227–237. [PubMed]
  • Wiener F, Spira J, Ohno S, Haran-Ghera N, Klein G. Chromosome changes (trisomy 15) in murine T-cell leukemia induced by 1,12-dimethylbenz(a)anthracene (DMBA). Int J Cancer. 1978 Oct 15;22(4):447–453. [PubMed]
  • Wiener F, Ohno S, Spira J, Haran-Ghera N, Klein G. Cytogenetic mapping of the trisomic segment of chromosome 15 in murine T-cell leukaemia. Nature. 1978 Oct 19;275(5681):658–660. [PubMed]
  • Dulbecco R, Vogt M. SIGNIFICANCE OF CONTINUED VIRUS PRODUCTION IN TISSUE CULTURES RENDERED NEOPLASTIC BY POLYOMA VIRUS. Proc Natl Acad Sci U S A. 1960 Dec;46(12):1617–1623. [PMC free article] [PubMed]
  • Stiles CD, Desmond W, Jr, Sato G, Saier MH., Jr Failure of human cells transformed by simian virus 40 to form tumors in athymic nude mice. Proc Natl Acad Sci U S A. 1975 Dec;72(12):4971–4975. [PMC free article] [PubMed]
  • Ozer HL, Jha KK. Malignancy and transformation: expression in somatic cell hybrids and variants. Adv Cancer Res. 1977;25:53–93. [PubMed]
  • Steinitz M, Klein G. Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3518–3520. [PMC free article] [PubMed]
  • Steinitz M, Klein G. Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro EBV converted, virus-genome carrying sublines. Eur J Cancer. 1977 Nov;13(11):1269–1275. [PubMed]
  • Yefenof E, Klein G. Difference in antibody induced redistribution of membrane IgM in EBV geonome free and EBV positive human lymphoid cells. Exp Cell Res. 1976 Apr;99(1):175–178. [PubMed]
  • Yefenof E, Klein G, Ben-Bassat H, Lundin L. Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines. Exp Cell Res. 1977 Aug;108(1):185–190. [PubMed]
  • Einhorn L, Ernberg I. Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer. 1978 Feb 15;21(2):157–160. [PubMed]
  • Robinson J. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood. J Virol. 1975 May;15(5):1065–1072. [PMC free article] [PubMed]
  • Gerber P, Hoyer BH. Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus. Nature. 1971 May 7;231(5297):46–47. [PubMed]
  • Gershon D, Hausen P, Sachs L, Winocour E. On the mechanism of polyoma virus-induced synthesis of cellular DNA. Proc Natl Acad Sci U S A. 1965 Dec;54(6):1584–1592. [PMC free article] [PubMed]
  • Stehelin D, Varmus HE, Bishop JM, Vogt PK. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature. 1976 Mar 11;260(5547):170–173. [PubMed]
  • Yamamoto T, Hayashi M, Rabinowitz Z, Sachs L. Chromosomal control of malignancy in tumours from cells transformed by polyoma virus. Int J Cancer. 1973 May;11(3):555–566. [PubMed]
  • Benedict WF, Rucker N, Mark C, Kouri RE. Correlation between balance of specific chromosomes and expression of malignancy in hamster cells. J Natl Cancer Inst. 1975 Jan;54(1):157–162. [PubMed]
  • Basilico C. Temperature-sensitive mutations in animal cells. Adv Cancer Res. 1977;24:223–266. [PubMed]
  • Harris H, Miller OJ, Klein G, Worst P, Tachibana T. Suppression of malignancy by cell fusion. Nature. 1969 Jul 26;223(5204):363–368. [PubMed]
  • Klein G, Bregula U, Wiener F, Harris H. The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci. 1971 May;8(3):659–672. [PubMed]
  • Harris H. Cell fusion and the analysis of malignancy. Proc R Soc Lond B Biol Sci. 1971 Oct 12;179(1054):1–20. [PubMed]
  • Harris H, Wiener F, Klein G. The analysis of malignancy by cell fusion. 3. Hybrids between diploid fibroblasts and other tumour cells. J Cell Sci. 1971 May;8(3):681–692. [PubMed]
  • Jonasson J, Povey S, Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci. 1977 Apr;24:217–254. [PubMed]
  • Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585–3589. [PMC free article] [PubMed]
  • Rossi GB, Friend C. Erythrocytic maturation of (Friend) virus-induced leukemic cells in spleen clones. Proc Natl Acad Sci U S A. 1967 Oct;58(4):1373–1380. [PMC free article] [PubMed]
  • Azumi JI, Sachs L. Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci U S A. 1977 Jan;74(1):253–257. [PMC free article] [PubMed]
  • FOULDS L. The natural history of cancer. J Chronic Dis. 1958 Jul;8(1):2–37. [PubMed]
  • Kaschka-Dierich C, Adams A, Lindahl T, Bornkamm GW, Bjursell G, Klein G, Giovanella BC, Singh S. Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature. 1976 Mar 25;260(5549):302–306. [PubMed]
  • Kaschka-Dierich C, Falk L, Bjursell G, Adams A, Lindahl T. Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells. Int J Cancer. 1977 Aug 15;20(2):173–180. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...